Asante Capital congratulates its partner Norvestor on closing Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion

We are delighted to share that Norvestor, a leading private equity firm in the Nordics, has closed Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion, exceeding its €1.25 billion target, despite a challenging fundraising environment.

With Norvestor IX, the firm will pursue extensive opportunities within the Nordics services and solutions sectors across technology-enabled, consumer, business and industrial solutions. The fund is nearly double the size of its predecessor fund and was oversubscribed, reflecting the conviction around Norvestor’s value-creation proposition.

Asante served as the exclusive global fundraising adviser.

About Norvestor

Established in 1989, Norvestor is one of the most established private equity firms in the Nordics, with over three decades of heritage in the region. Norvestor maintains offices in Oslo, Stockholm, Helsinki, Copenhagen, Berlin and Luxembourg, providing the team a truly local presence and comprehensive coverage of the full opportunity landscape. The Norvestor funds seek to invest in growth companies in the Nordic mid-market that have potential to achieve a leading Nordic or international position, typically through organic growth, acquisitions across fragmented industries and by geographic expansion. Read more at www.norvestor.com

About Asante

Asante Capital Group is a leading independent private equity placement and advisory group. Founded in 2010, the firm has offices in London, New York City, Hong Kong, and Munich. The team of over 70 professionals has advised on over $80 billion of successful private capital raisings across the globe, raising capital from North American, European, Middle East and Asia-Pacific-based investors. Asante specializes in GP advisory and fundraising support across primary, direct and secondary investments.

Asante Capital congratulates partner Abingworth on the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million

We are delighted to share that Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million.

Asante is excited to announce the global expansion of our secondaries business

Asante is excited to announce that Director Sam Cantor is relocating to our New York City office, further strengthening the global expansion of our secondaries business.

Asante Capital Named to PEI’s Inaugural Top Private Equity Placement Agents of 2023

Asante Capital was ranked as one of Private Equity International’s Top Private Equity Placement Agents of 2023, ranking fourth for overall capital raised across all private market strategies and third for both the APAC and North America regions. PEI’s inaugural list looked at the most active placement agents and winners were chosen based on their performance, rather than submission.